Teladoc Health
TDOC
431 hedge funds and large institutions have $3.27B invested in Teladoc Health in 2023 Q2 according to their latest regulatory filings, with 55 funds opening new positions, 125 increasing their positions, 143 reducing their positions, and 50 closing their positions.
42% more call options, than puts
Call options by funds: $143M | Put options by funds: $100M
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
10% more first-time investments, than exits
New positions opened: 55 | Existing positions closed: 50
0% more funds holding
Funds holding: 429 → 431 (+2)
4.53% less ownership
Funds ownership: 83.34% → 78.81% (-4.5%)
8% less capital invested
Capital invested by funds: $3.54B → $3.27B (-$273M)
13% less repeat investments, than reductions
Existing positions increased: 125 | Existing positions reduced: 143
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Man Group
London,
United Kingdom
|
+$38.4M |
| 2 |
Balyasny Asset Management
Chicago,
Illinois
|
+$32.6M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$31.9M |
| 4 |
Renaissance Technologies
New York
|
+$26.1M |
| 5 |
HRCM
Hood River Capital Management
Palm Beach Gardens,
Florida
|
+$24.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
-$76.8M |
| 2 |
Two Sigma Investments
New York
|
-$61.7M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$47M |
| 4 |
Millennium Management
New York
|
-$39.1M |
| 5 |
BlackRock
New York
|
-$29.4M |
TDOC Hedge Fund Activity: Q2 2023 in Review
431 of the 6,383 institutional investors tracked by Wall St. Rank reported a position in Teladoc Health (TDOC) for Q2 2023, worth a combined $3.27B — down 7.7% from $3.54B a quarter earlier.
Buyers outnumbered sellers: 55 funds opened new TDOC positions and 50 closed out — a net gain of 5 holders — while 125 added to existing stakes and 143 trimmed.
The largest buyer was Man Group, opening a new position worth an estimated $38.4M. The largest seller was Baillie Gifford & Co, cutting an estimated $76.8M.
- 431 institutional investors held Teladoc Health (TDOC) as of Q2 2023, up from 429 in Q1 2023.
- Funds reported $3.27B of Teladoc Health stock for Q2 2023, down 7.7% quarter-over-quarter.
- 55 funds opened new Teladoc Health positions in Q2 2023 and 50 closed out, a net change of +5 holders.
- The largest Teladoc Health buyer in Q2 2023 was Man Group, an estimated $38.4M added.
- The largest Teladoc Health seller in Q2 2023 was Baillie Gifford & Co, an estimated $76.8M sold.
Based on aggregated 13F filings for Q2 2023.